2024 / 11 / 21

PharmaEssentia Achieves Record High Scores in the 2024 S&P Global Sustainability Assessment(UPDATED)

The 99th percentile (Top 1%) of the S&P Global ESG Performance in the global Biotechnology industry

2024 / 10 / 30

PharmaEssentia Achieves Record High Scores in the 2024 S&P Global Sustainability Assessment

Achieved an outstanding score in the social dimension, contributing to healthcare and talent management

2024 / 09 / 25

PharmaEssentia Summer Internship Program: Future Pharmaceutical Professionals to Advance Corporate Sustainability

Aligning with the UN SDGs and Committing to Talent Development and Sustainable Growth

2024 / 08 / 09

PharmaEssentia Partners with NPOs at 2024 SDG Asia Sustainability Salon to Drive Business and ESG Social Impact

Responding to promote "With technology's love, eliminate health inequity" for the SDGs

2024 / 07 / 31

PharmaEssentia Enhances Information Security Management System: Achieves ISO/IEC 27001:2022 International Certification

Achieving ISO/IEC 27001:2022 International Certification Brings Competitive Advantages

2024 / 06 / 28

PharmaEssentia (stock code: 6446) has released "2023 ESG Sustainability Report"

In 2023, ESG performance showcased 46 highlights, demonstrating Authentic and Eternal Value Creating

We use cookies to enhance your browsing experience and for web traffic statistics purposes. By using this website, you agree to our cookies technical support. Learn more, please refer to our PRIVACY AND COOKIES PLOICY. Privacy policy